OB/GYN Clinical Alert articles from September 2003

OB/GYN Clinical Alert archives from September 2003

Postmenopausal hormone therapy and coronary heart disease.(Author Abstract)
September 1, 2003... Synopsis: The WHI and the WELL-HART clinical trials report that hormone therapy does not reduce the risk of coronary events or slow the progression of atherosclerosis in older women. MANSON AND COLLEAGUES REPORTED THE FINAL RESULTS ON the...

12 vs 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after platinum and paclitaxel-based chemotherapy.(Author Abstract)
September 1, 2003... Synopsis: Twelve cycles of single-agent paclitaxel administered to women with advanced ovarian cancer who attain a clinically defined complete response to initial platinum/paclitaxel-based chemotherapy significantly prolongs the duration of...

Fetal assessment comparing nonstress test with umbilical artery doppler velocimetry.( )(Author Abstract)
September 1, 2003... Synopsis: Umbilical artery Doppler as a screening test for fetal well-being in a high-risk population was associated with a decreased incidence of cesarean delivery for fetal distress compared to the nonstress testing, with no increase in...

Ultrasound evaluations of cervical length in preterm labor.(Author Abstract)
September 1, 2003... Synopsis: In women with threatened preterm labor, sonographic measurement of cervical length helps distinguish between true and false labor. Source: Tsoi E, et al. Ultrasound Obstet Gynecol. 2003;21(6):552-555. I REALIZE THAT MANY OF...

CME questions.(continuing medical education)(Brief Article)
September 1, 2003... 6. The following statements are true regarding the risk of coronary heart disease according to the WHI except: a. "Adjudication" means that clinical diagnoses made by local clinicians are reviewed and affirmed or changed. b. According...

Study shows oral IIb/IIIa receptors increase mortality.(Pharmacology Watch)
September 1, 2003... Another study has shown an increase in mortality associated with the use of an oral IIb/IIIa receptor antagonist. The use of intravenous IIb/IIIa inhibitors has become commonplace in the setting of acute coronary syndrome and percutaneous...

Prognostic value of ABPMs in patients with treated hypertension.(ambulatory blood pressure monitoring)(Author Abstract)
September 1, 2003... Source: Clement DL, et al. N Engl J Med. 2003;348(24):2407-2415. AMBULATORY BLOOD PRESSURE MONITORING (ABPM) has been available for more than a decade, yet it has not attracted routine application in clinical practice. Several factors have...

Tazarotene cream in the treatment of psoriasis.(Author Abstract)
September 1, 2003... Source: Weinstein GD, et al. J Am Acad Dermatol. 2003;48:760-767. TAZAROTENE (TZT) IS A RECEPTOR-selective retinoid used topically. Tazarotenic acid, the primary metabolite of TZT, binds to the retinoic acid receptor-gamma sites in the...

Antihyperglycemic effect of oolong tea in type 2 diabetes.(Author Abstract)
September 1, 2003... Source: Hosoda K, et al Diabetes Care. 2003;26(6):1714-1718. ANIMAL STUDIES HAVE SHOWS THAT tea consumption can reduce plasma glucose. Teas fall into three primary categories: green, oolong, and black, which, though they all come from the...

Metformin and thiazolidinedione use in Medicare patients with heart failure.(Author Abstract)
September 1, 2003... Source: Masoudi FA, et al. JAMA. 2003;290:81-85. WITH EXPERT GUIANCE ENCOURaging increasingly austere levels of A1C control for diabetics, clinicians have been required to become more sophisticated and diversified in diabetes (DM)...

Alcohol consumption patterns and biologic markers of glycemic control.(Author Abstract)
September 1, 2003... Source: Kroenke CH, et al. Diabetes Care. 2003;26:1971-1978. SEVERAL DECADES OF OBSERVATIONAL data have indicated that moderate alcohol consumption (ALC) is associated with reduced incidence of cardiovascular end points, particularly stroke...

Azelaic acid gel as a new treatment for papulopustular rosacea.(Author Abstract)
September 1, 2003... Source: Thiboutot D, et al. J Am Acad Dermatol. 2003;48:836-845. ROSACEA (ROS), ALTHOUGH SOMETIMES called "acne rosacea," is unrelated pathophysiologically to acne. The pathology of ROS is characterized by vascular, inflammatory, and tissue...